These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23172310)

  • 1. Macrophage delivery of an oncolytic virus abolishes tumor regrowth and metastasis after chemotherapy or irradiation.
    Muthana M; Rodrigues S; Chen YY; Welford A; Hughes R; Tazzyman S; Essand M; Morrow F; Lewis CE
    Cancer Res; 2013 Jan; 73(2):490-5. PubMed ID: 23172310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
    Heinemann L; Simpson GR; Boxall A; Kottke T; Relph KL; Vile R; Melcher A; Prestwich R; Harrington KJ; Morgan R; Pandha HS
    BMC Cancer; 2011 Jun; 11():221. PubMed ID: 21645351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of macrophages to target therapeutic adenovirus to human prostate tumors.
    Muthana M; Giannoudis A; Scott SD; Fang HY; Coffelt SB; Morrow FJ; Murdoch C; Burton J; Cross N; Burke B; Mistry R; Hamdy F; Brown NJ; Georgopoulos L; Hoskin P; Essand M; Lewis CE; Maitland NJ
    Cancer Res; 2011 Mar; 71(5):1805-15. PubMed ID: 21233334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts.
    Radhakrishnan S; Miranda E; Ekblad M; Holford A; Pizarro MT; Lemoine NR; Halldén G
    Hum Gene Ther; 2010 Oct; 21(10):1311-25. PubMed ID: 20497039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic adenovirus carrying SPAG9-shRNA enhanced the efficacy of docetaxel for advanced prostate cancer.
    Lu M; Xu Z; Wei F; Wang J; Ma S; Kan Y; Li B; Wu C; Mao L
    Anticancer Drugs; 2022 Feb; 33(2):142-148. PubMed ID: 34561997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
    Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
    BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Van Roey M; Jooss K
    Clin Cancer Res; 2008 Jun; 14(12):3933-41. PubMed ID: 18559615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy.
    Li H; Nakashima H; Decklever TD; Nace RA; Russell SJ
    Cancer Gene Ther; 2013 Aug; 20(8):478-85. PubMed ID: 23868101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter.
    Hakkarainen T; Rajecki M; Sarparanta M; Tenhunen M; Airaksinen AJ; Desmond RA; Kairemo K; Hemminki A
    Clin Cancer Res; 2009 Sep; 15(17):5396-403. PubMed ID: 19706820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Ge Y; VanRoey M; Robinson M; Jooss K
    Cancer Gene Ther; 2009 May; 16(5):383-92. PubMed ID: 19011598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
    Kelly MP; Lee ST; Lee FT; Smyth FE; Davis ID; Brechbiel MW; Scott AM
    Prostate; 2009 Jan; 69(1):92-104. PubMed ID: 18942092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.
    Passer BJ; Castelo-Branco P; Buhrman JS; Varghese S; Rabkin SD; Martuza RL
    Cancer Gene Ther; 2009 Jul; 16(7):551-60. PubMed ID: 19197321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel followed by castration improves outcomes in LNCaP prostate cancer-bearing severe combined immunodeficient mice.
    Tang Y; Khan MA; Goloubeva O; Lee DI; Jelovac D; Brodie AM; Hussain A
    Clin Cancer Res; 2006 Jan; 12(1):169-74. PubMed ID: 16397039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.
    Bramante S; Kaufmann JK; Veckman V; Liikanen I; Nettelbeck DM; Hemminki O; Vassilev L; Cerullo V; Oksanen M; Heiskanen R; Joensuu T; Kanerva A; Pesonen S; Matikainen S; Vähä-Koskela M; Koski A; Hemminki A
    Int J Cancer; 2015 Oct; 137(7):1775-83. PubMed ID: 25821063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer.
    Fizazi K; Sikes CR; Kim J; Yang J; Martinez LA; Olive MC; Logothetis CJ; Navone NM
    Anticancer Res; 2004; 24(5A):2897-903. PubMed ID: 15517894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF blockade decreases the tumor uptake of systemic oncolytic herpes virus but enhances therapeutic efficacy when given after virotherapy.
    Eshun FK; Currier MA; Gillespie RA; Fitzpatrick JL; Baird WH; Cripe TP
    Gene Ther; 2010 Jul; 17(7):922-9. PubMed ID: 20508601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.
    Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA
    J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer.
    Shen Y; Ma Z; Chen F; Dong Q; Hu Q; Bai L; Chen J
    J Drug Target; 2015; 23(6):568-76. PubMed ID: 25738990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chemotherapy and chemotherapy: a new front against late-stage hormone-refractory prostate cancer.
    Singh PP; Joshi S; Russell PJ; Verma ND; Wang X; Khatri A
    Clin Cancer Res; 2011 Jun; 17(12):4006-18. PubMed ID: 21531822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.
    Chastkofsky MI; Pituch KC; Katagi H; Zannikou M; Ilut L; Xiao T; Han Y; Sonabend AM; Curiel DT; Bonner ER; Nazarian J; Horbinski CM; James CD; Saratsis AM; Hashizume R; Lesniak MS; Balyasnikova IV
    Clin Cancer Res; 2021 Mar; 27(6):1766-1777. PubMed ID: 33272983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.